BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4619922)

  • 21. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conceptualizing schizophrenia through attenuated symptoms in the population.
    Carpenter WT
    Am J Psychiatry; 2010 Sep; 167(9):1013-6. PubMed ID: 20826849
    [No Abstract]   [Full Text] [Related]  

  • 23. [Stability of positive/negative symptoms in schizophrenia].
    Ribeyre JM; Dollfus S
    Encephale; 1996 Jun; 22 Spec No 2():29-31. PubMed ID: 8767039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suspiciousness and alcohol use disorders in schizophrenia.
    Messias E; Bienvenu OJ
    J Nerv Ment Dis; 2003 Jun; 191(6):387-90. PubMed ID: 12826920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia.
    Chang JS; Yi JS; Ahn YM; Kim JH; Kim YS
    Aust N Z J Psychiatry; 2009 Mar; 43(3):244-51. PubMed ID: 19221913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polydiagnostic approach to schizophrenia. Validation of a computerized checklist (Diagnostic and Prognostic Scales)].
    Dollfus S; Petit M; Ménard JF; Brazo P; Assouly-Besse F; Preterre P; Lesieur P
    Encephale; 1994; 20(2):91-101. PubMed ID: 8050383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The WHO Psychological Impairments Rating Schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept.
    Biehl H; Maurer K; Jablensky A; Cooper JE; Tomov T
    Br J Psychiatry Suppl; 1989 Nov; (7):68-70. PubMed ID: 2619983
    [No Abstract]   [Full Text] [Related]  

  • 28. Obsessive compulsive disorder with psychotic features.
    Eisen JL; Rasmussen SA
    J Clin Psychiatry; 1993 Oct; 54(10):373-9. PubMed ID: 8262879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of professional and self evaluation scales in chronic schizophrenic patients].
    Simhandl C; Rogan M; Lesch OM; Musalek M; Strobl R
    Nervenarzt; 1984 Jul; 55(7):371-7. PubMed ID: 6472527
    [No Abstract]   [Full Text] [Related]  

  • 30. The prevalence and correlates of trauma-related symptoms in schizophrenia spectrum disorder.
    Lysaker PH; Larocco VA
    Compr Psychiatry; 2008; 49(4):330-4. PubMed ID: 18555051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The WHO Psychological Impairments Rating Schedule (WHO/PIRS). II. Impairments in Schizophrenics in cross-sectional and longitudinal perspective--the Mannheim experience in two independent samples.
    Biehl H; Maurer K; Jung E; Krumm B
    Br J Psychiatry Suppl; 1989 Nov; (7):71-7. PubMed ID: 2619984
    [No Abstract]   [Full Text] [Related]  

  • 32. [Is the concept of post-traumatic schizophrenia recognized and used by French psychiatrists? Aspects of a statistical survey and a clinical study].
    Léger JM; Plougeaut C; Dumond JJ; Garoux R
    Ann Med Psychol (Paris); 1992; 150(6):429-35; discussion 435-6. PubMed ID: 1342773
    [No Abstract]   [Full Text] [Related]  

  • 33. Schneider's first-rank symptoms of schizophrenia: prevalence and diagnostic use. A study from Pakistan.
    Malik SB; Ahmed M; Bashir A; Choudhry TM
    Br J Psychiatry; 1990 Jan; 156():109-11. PubMed ID: 2297605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-rank symptoms or rank-and-file symptoms?
    Crichton P
    Br J Psychiatry; 1996 Nov; 169(5):537-40; discussion 541-50. PubMed ID: 8932880
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cultural factors and schizophrenic symptoms; comparative studies in Malta and in Poland].
    Masłowski J
    Psychiatr Pol; 1991; 25(1):41-9. PubMed ID: 1780373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia: a multinational study. Discussion and conclusions.
    Public Health Pap; 1975; (63):136-46. PubMed ID: 1105986
    [No Abstract]   [Full Text] [Related]  

  • 37. [Symptomatology of speech disorders in schizophrenia in the light of modern research. II].
    Rogovin MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(1):141-6. PubMed ID: 4466224
    [No Abstract]   [Full Text] [Related]  

  • 38. Interethnic variations in the presence of Schneiderian first rank symptoms.
    Coffey GJ; Mackinnon A; Minas IH
    Aust N Z J Psychiatry; 1993 Jun; 27(2):219-27. PubMed ID: 8363531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom patterns related to somatosensory evoked response differences within a schizophrenic population.
    Shagass C; Soskis DA; Straumanis JJ; Overton DA
    Biol Psychiatry; 1974 Aug; 9(1):25-43. PubMed ID: 4457116
    [No Abstract]   [Full Text] [Related]  

  • 40. Methylphenidate challenge tests and course of schizophrenia.
    Lieberman JA; Kane JM; Gadaletta D; Ramos-Lorenzi J; Bergmann K; Wegner J; Novacenko H
    Psychopharmacol Bull; 1985; 21(1):123-9. PubMed ID: 3983333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.